16:09 EST Voyager Therapeutics (VYGR) files $400M mixed securities shelf
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VYGR:
- Voyager Therapeutics price target lowered to $11 from $12 at Leerink
- Voyager Therapeutics reports Q3 EPS (47c), consensus (52c)
- Voyager Therapeutics expects cash to fund operations into 2028
- Voyager Therapeutics, Transition Bio entered into drug discovery collab
- Voyager Therapeutics Advances Alzheimer’s Study with VY7523